All In MedTech

Device Trial Radar · NCT00069628

Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer

DirecNet Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer in the Management of Type 1 Diabetes in Children

Last checked: Nov 20, 2026Latest source record: Sep 5, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Jul 2003

Primary completion

Not stated

Study completion Nov 2004

Sponsor

Lead sponsor
Jaeb Center for Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Sep 30, 2003

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and effectiveness of a continuous glucose monitor in children with Type 1 diabetes mellitus (T1DM).

Conditions

  • Diabetes Mellitus, Insulin-Dependent

Interventions

  • GlucoWatch® G2™ Biographer (GW2B)Device

  • Continuous Glucose Monitoring System (CGMS)Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HbA1c value obtained 6 months after randomization

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Division of Pediatric Endocrinology and Diabetes, Stanford University

    Stanford, California

  • Barbara Davis Center for Childhood Diabetes, University of Colorado

    Denver, Colorado

  • Department of Pediatrics, Yale University School of Medicine

    New Haven, Connecticut

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.